NewzA delegation from the European Parliament’s Public Health Committee recently visited Greece to assess the domestic pharmaceutical industry. During the visit, the Panhellenic Union of Pharmaceutical Industry highlighted the sector's role in bolstering the continent's drug production capacity and supply chain stability.
The industry is being positioned as a critical component of Europe’s broader strategic autonomy in healthcare. By expanding local manufacturing capabilities, the Greek pharmaceutical sector aims to enhance regional drug security and reduce dependency on external supply sources.
In-depth summary · AI, neutral